Skip to main content
. 2022 Jul 22;13:896227. doi: 10.3389/fendo.2022.896227

Table 1.

Hormone profiles of the patient.

Parameter June 2018 Nov. 2019 Reference range
FSH 1.14 1.37 F:3.5-12.5; O:4.7-21.5;
L:1.7-7.7; M:25.8-134.8IU/L
LH <0.20 <0.20 F:2.4-12.6; O:14.0-95.6;
L:1.0-11.4; M:7.7-58.5IU/L
Estradiol <5 29 F:12.5-166; O:85.8-498;
L:43.8-211; M: <5.0-54.7pg/mL
Progesterone <0.05 0.82 F:0.2-1.5; O:0.8-3.8;
L:1.7-27; M:0.1-0.8ng/mL
Testosterone <0.025 0.24 0.1-0.75ng/mL
Prolactin 142.3 52.07 4.79-28.3ng/mL
SHBG 103.2 34.5 26.1-100nmol/L
ACTH(8AM) 1.74 0.53 1.1-11.0pmol/L
Cortisol(8AM) 33.80 34.53 42-248ug/L
Cortisol(4PM) 33.12 33.07 29-173ug/L
Cortisol(12MN) 16.40 32.47 0-67ug/L
TSH 0.349 0.604 0.27–4.2uIU/mL
fT3 3.02 2.66 2.0–4.4pg/mL
fT4 10.98 13.28 9.32–17.09pg/mL

FSH, Follicle-Stimulating Hormone; LH, Luteinizing Hormone; SHBG, sex hormone-binding globulin; F, follicular phase; O, ovulatory phase; L, luteal phase; M, menopause; ACTH, adrenocorticotropin; TSH, thyroid stimulating hormone; fT3, free triiodothyronine; fT4, free thyroxine.